Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2017/0334907 |
BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY The invention relates to bicyclic heterocycle compounds of formula (I): ##STR00001## or tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically... |
| 2017/0334906 |
NEW COMPOUNDS AS NIK INHIBITORS The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of ... |
| 2017/0334905 |
NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce... |
| 2017/0334904 |
PYRIMIDO[4,5-B]INDOLE DERIVATIVES AND USE THEREOF IN THE EXPANSION OF
HEMATOPOIETIC STEM CELLS Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic... |
| 2017/0334903 |
METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal... |
| 2017/0334902 |
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically... |
| 2017/0334901 |
QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS The invention provides novel quinolinone-carboxamide 5-HT.sub.4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising... |
| 2017/0334900 |
NEW PYRAZOLE DERIVATIVES AS NIK INHIBITORS The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of ... |
| 2017/0334899 |
AMINO-SUBSTITUTED ISOTHIAZOLES The present invention relates to amino-substituted isothiazoles of general formula (I): in which A, R1 and R2 are as defined in the claims, to methods of... |
| 2017/0334898 |
NOVEL 4-METHYL-DIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF
HEPATITIS B VIRUS INFECTION The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, M and X are as described... |
| 2017/0334897 |
Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases,
Disorders And Conditions Described herein are liver X receptor (LXR) modulators and methods of milizing LXR modulators in the treatment of dermal diseasess, disorders or conditions.... |
| 2017/0334896 |
Substituted Heterocyclic Derivative, Preparation Method And Use Thereof The invention provides a compound as shown by Formula I having an enzyme activity which can inhibit endocannabinoid hydrolases NAAA and/or FAAH, or a... |
| 2017/0334895 |
DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical... |
| 2017/0334894 |
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof The present invention provides compounds of Formula I: ##STR00001## and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these... |
| 2017/0334893 |
Isoxazole Analogs as FXR Agonists and Methods of Use Thereof The present invention provides compounds of Formula I: ##STR00001## pharmaceutical compositions comprising these compounds and methods of using these compounds... |
| 2017/0334892 |
LKB1-AMPK ACTIVATORS FOR THERAPEUTIC USE IN POLYCYSTIC KIDNEY DISEASE Compounds are provided for use in treating polycystic kidney disease (PKD) and in associated methods that include a method of modulating (e.g., activating)... |
| 2017/0334891 |
ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions... |
| 2017/0334890 |
SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to... |
| 2017/0334889 |
COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED
PROTEIN RESPONSE N-substituted sulfonylphenyl-5-nitrofuranyl-2-carboxamide derived compounds, which selectively activate the apoptotic, but not the adaptive arm, of the... |
| 2017/0334888 |
SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel... |
| 2017/0334887 |
Imidazole-Based Antimicrobial Agents The present invention relates to novel therapeutic agents suitable for use in the treatment of mammalian disease and in particular to novel therapeutic agents... |
| 2017/0334886 |
N-SUBSTITUTED 4-AMINOQUINAZOLINE DERIVATIVES AND METHODS OF USE The present invention provides kinase inhibitor analogs with improved properties, such as improved efficacy, pharmacokinetics, safety, and specificity. In some... |
| 2017/0334885 |
PYRAZOLE COMPOUNDS This invention relates to pyrazole compounds or pharmaceutically acceptable salts thereof. Compounds of this invention are inhibitors of methionine... |
| 2017/0334884 |
PROCESS FOR THE PURIFICATION OF THE AXL TYROSINE RECEPTOR KINASE INHIBITOR
"R428" A process for purifying 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine-3-yl)-N.sup.3-(7-- ... |
| 2017/0334883 |
THERAPEUTIC COMPOUNDS AND USES THEREOF The present invention relates to methods for treating PCAF mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: ... |
| 2017/0334882 |
HEPATITIS B ANTIVIRAL AGENTS The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to... |
| 2017/0334881 |
NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES The invention provides certain nicotine salts, co-crystals, and salt co-crystals and provides novel polymorphic forms of certain nicotine salts. In particular,... |
| 2017/0334880 |
PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL DISEASES The present invention relates to novel compounds of formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in... |
| 2017/0334879 |
HISTONE DEMETHYLASE INHIBITORS The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted ... |
| 2017/0334878 |
SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES AND
2-ARYL-6-AMINOPYRIMIDINE-4-CARBOXYLATES BY DIRECT SUZUKI COUPLING Improved methods of synthesizing 6-aryl-4-aminopicolinates, such as arylalky and alkyl ... |
| 2017/0334877 |
REVAPRAZAN HYDROCHLORIDE POLYMORPHS AND PREPARATION METHOD THEREFOR Provided are revaprazan hydrochloride polymorphs and a preparation method thereof. The method comprises a step of dissolving revaprazan hydrochloride in... |
| 2017/0334876 |
NOVEL CYCLIC COMPOUND AND OPTICAL MATERIAL COMPOSITION INCLUDING SAME One embodiment of the present invention can provide an optical material composition that includes a cyclic compound that is represented by formula (1) and an... |
| 2017/0334875 |
METHOD FOR THE PRODUCTION OF VITAMIN E WITH A HIGH PURITY, VITAMIN E
PRODUCED BY SAID METHOD, AND A COMPOSITION... A method is provided for manufacturing high-purity vitamin E compounds by selectively separating vitamin E compounds such as tocotrienols and tocopherols from... |
| 2017/0334874 |
PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as... |
| 2017/0334873 |
KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A,... |
| 2017/0334872 |
SEMI-SYNTHESIS PROCEDURES Provided herein are improved processes for convening C7-amino-substituted tetracylines to C7-fluoro-substituted tetracyclines as well as intermediates produced... |
| 2017/0334871 |
Thymoquinone Derivatives for Treatment of Cancer The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer. ... |
| 2017/0334870 |
PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain... |
| 2017/0334869 |
NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND
CANCER The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and... |
| 2017/0334868 |
COMPOSITIONS AND METHODS OF TREATMENT WITH PRODRUGS OF TIZOXANIDE, AN
ANALOGUE OR SALT THEREOF Prodrugs of tizoxanide, an analogue or salt thereof are disclosed. The prodrugs have an ester moiety comprising an amino acid moiety, and increase the... |
| 2017/0334867 |
PROTEASE INHIBITORS Compounds of the formula II: ##STR00001## wherein R.sup.1 and R.sup.2 are independently H, F or CH.sub.3 ; or R.sup.1 forms an ethynyl bond and R.sup.2 is H or... |
| 2017/0334866 |
CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-.gamma.-lyase (CSE). Also described herein... |
| 2017/0334865 |
DDR2 INHIBITORS AND METHODS OF USING Compounds that inhibit activation of Discoidin Domain Receptor 2 (DDR2) and methods of using the compounds to inhibit DDR2 activation, inhibit migration of... |
| 2017/0334864 |
3,5-DIAMINO-6-CHLORO-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTAHYDROXYHEXYL)AMIN-
O)ETHOXY)PHENYL)BUTYL)... The present invention relates to the compound of the formula: ##STR00001## or pharmaceutically acceptable salts thereof, as well as compositions containing the... |
| 2017/0334863 |
Cdc42 INHIBITOR AND USES THEREOF Compounds which inhibit the small G protein Rho GTPase cell division cycle protein Cdc42 are provided. Morphological analyses of filopodia, western blots of... |
| 2017/0334862 |
IMIDAZOLE DERIVATIVES AS PRODRUGS OF DICLOFENAC The present invention relates to a compound of formula (I): ##STR00001## wherein R.sub.1 is R.sub.3-IPU and R.sub.2 is the acyloxy residue of diclofenac, and... |
| 2017/0334861 |
TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present... |
| 2017/0334860 |
NOVEL POLYMORPHS OF IVACAFTOR, PROCESS FOR ITS PREPARATION AND
PHARMACEUTICAL COMPOSITION THEREOF The present invention relates to novel polymorphic forms of ivacaftor, process for its preparation and pharmaceutical compositions comprising the same. |
| 2017/0334859 |
CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described. |
| 2017/0334858 |
PROCESS FOR THE PREPARATION OF INTERMEDIATE OF DOLUTEGRAVIR The present invention provides a novel processes for preparation of methyl 3-(benzyloxy)-5-(2,4-difluorobenzylcarbamoyl)-4-oxo-1-(2-oxoethyl)- ... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.